Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Exostoses, multiple, type 1, 133700, Autosomal dominant (Multiple osteochondromas) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
EXT1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 253 | 189 |
|
Invitae Skeletal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 624 | 349 |
|
HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Multiple exostoses Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Multiple exostoses Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
PreventionGenetics, part of Exact Sciences United States | 77 | 64 |
|
Multiple exostoses Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Multiple exostoses Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
HNL Genomics Connective Tissue Gene Tests United States | 2 | 2 |
|
Invitae Congenital Disorders of Glycosylation Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 203 | 152 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.